Visilizumab
Jump to navigation
Jump to search
Template:Drugbox-mab Visilizumab (marketed under the trade name Nuvion by PDL BioPharma Inc.) is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn disease. Visilizumab binds to the CD3 receptor on certain activated T cells without effecting resting T cells.
External link
 | This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
Template:Immunosuppressants Template:Humanizedmonoclonals Template:WikiDoc Sources